David P Hatch

Array ( [id] => 4186589 [patent_doc_number] => 06042836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'HIV envelope polypeptides' [patent_app_type] => 1 [patent_app_number] => 9/134075 [patent_app_country] => US [patent_app_date] => 1998-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 35015 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042836.pdf [firstpage_image] =>[orig_patent_app_number] => 134075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4299508 [patent_doc_number] => 06251582 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Alternative G-coupled receptors associated with retroviral entry into cells, methods of identifying the same, and diagnostic and therapeutic uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/116498 [patent_app_country] => US [patent_app_date] => 1998-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 23860 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251582.pdf [firstpage_image] =>[orig_patent_app_number] => 116498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186960 [patent_doc_number] => 06153392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Devices and methods comprising an HBcAg from hepatitis B virus' [patent_app_type] => 1 [patent_app_number] => 9/115350 [patent_app_country] => US [patent_app_date] => 1998-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14649 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153392.pdf [firstpage_image] =>[orig_patent_app_number] => 115350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4413911 [patent_doc_number] => 06193981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-27 [patent_title] => 'Methods and compositions for impairing multiplication of HIV-1' [patent_app_type] => 1 [patent_app_number] => 9/113921 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23560 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/193/06193981.pdf [firstpage_image] =>[orig_patent_app_number] => 113921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239379 [patent_doc_number] => 06143865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Epstein-Barr virus peptides and antibodies against these peptides' [patent_app_type] => 1 [patent_app_number] => 9/074114 [patent_app_country] => US [patent_app_date] => 1998-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 9187 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143865.pdf [firstpage_image] =>[orig_patent_app_number] => 074114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232730 [patent_doc_number] => 06090390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Diagnostic test for equine arteritis virus mediated disease' [patent_app_type] => 1 [patent_app_number] => 8/981459 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 4784 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090390.pdf [firstpage_image] =>[orig_patent_app_number] => 981459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4353780 [patent_doc_number] => 06254872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Multi-subtype FIV vaccines' [patent_app_type] => 1 [patent_app_number] => 9/025610 [patent_app_country] => US [patent_app_date] => 1998-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 11546 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/254/06254872.pdf [firstpage_image] =>[orig_patent_app_number] => 025610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240700 [patent_doc_number] => 06136319 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Method of treating viral diseases in animals' [patent_app_type] => 1 [patent_app_number] => 9/013760 [patent_app_country] => US [patent_app_date] => 1998-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 13035 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136319.pdf [firstpage_image] =>[orig_patent_app_number] => 013760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933026 [patent_doc_number] => 05972633 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Antibodies against heart muscle actin' [patent_app_type] => 1 [patent_app_number] => 8/930695 [patent_app_country] => US [patent_app_date] => 1998-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1463 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972633.pdf [firstpage_image] =>[orig_patent_app_number] => 930695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241362 [patent_doc_number] => 06080846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Composition containing a B epitope of the envelope glycoprotein of a retrovirus and a T epitope of another distinct protein of this retrovirus' [patent_app_type] => 1 [patent_app_number] => 8/969455 [patent_app_country] => US [patent_app_date] => 1997-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8211 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 349 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080846.pdf [firstpage_image] =>[orig_patent_app_number] => 969455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937501 [patent_doc_number] => 05976539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Compositions and methods for use of IL-12 as an adjuvant' [patent_app_type] => 1 [patent_app_number] => 8/965688 [patent_app_country] => US [patent_app_date] => 1997-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 12693 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976539.pdf [firstpage_image] =>[orig_patent_app_number] => 965688 [rel_patent_id] =>[rel_patent_doc_number] =>)